Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




CMM and Qiagen Focus on Molecular Diagnostic Markers

By Labmedica staff writers
Posted on 13 Mar 2008
The Center for Molecular Medicine (CMM; Grand Rapids, MI, USA) and Qiagen NV (Frankfurt, Germany) have agreed to collaborate on the discovery of molecular biomarkers that will help diagnose breast cancer and other women's diseases. More...
Financial terms of the agreement were not disclosed.

CMM has access to clinical samples, molecular analysis capabilities, and XenoBase-- software and a database system developed at the Van Andel Research Institute (Grand Rapids, MI, USA). This bio-informatic system is capable of analyzing a wide range of molecular and conventional clinical data to help scientists identify clinical associations between diseases, biomarkers, and treatments. Following Qiagen's initial results, CMM might also provide laboratory-based genomics and proteomics services to assist Qiagen in the development and validation of new molecular diagnostic tests.

CMM is a Clinical Laboratory Improvement Amendments (CLIA)-certified, College of American Pathologists (CAP)-accredited, clinical diagnostics laboratory. CMM's capabilities, including XenoBase access, on-site microarray-based DNA typing, and gene expression played a role in bringing Qiagen to West Michigan.

Qiagen is a provider of sample and assay technologies and products that are considered standards in areas such pre-analytic sample preparation and assay solutions in molecular diagnostics, life sciences, and applied testing. Qiagen has developed a comprehensive range of more than 500 consumable products and automated systems for sample collection, nucleic acid and protein handling, separation, and purification, and open and target specific assays.


Related Links:
Center for Molecular Medicine
Qiagen
Van Andel Research Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.